TissGeneSummary for AQP2 |
Gene summary |
Basic gene information | Gene symbol | AQP2 |
Gene name | aquaporin 2 (collecting duct) | |
Synonyms | AQP-CD|WCH-CD | |
Cytomap | UCSC genome browser: 12q12-q13 | |
Type of gene | protein-coding | |
RefGenes | NM_000486.5, | |
Description | ADH water channelAQP-2aquaporin-2aquaporin-CDcollecting duct water channel proteinwater channel protein for renal collecting ductwater-channel aquaporin 2 | |
Modification date | 20141222 | |
dbXrefs | MIM : 107777 | |
HGNC : HGNC | ||
Ensembl : ENSG00000167580 | ||
HPRD : 00141 | ||
Vega : OTTHUMG00000169709 | ||
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_AQP2 | |
BioGPS: 359 | ||
Pathway | NCI Pathway Interaction Database: AQP2 | |
KEGG: AQP2 | ||
REACTOME: AQP2 | ||
Pathway Commons: AQP2 | ||
Context | iHOP: AQP2 | |
ligand binding site mutation search in PubMed: AQP2 | ||
UCL Cancer Institute: AQP2 | ||
Assigned class in TissGDB* | C | |
Included tissue-specific gene expression resources | TiGER,GTEx | |
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | KidneyProstate | |
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | KIRC,KIRP,KICHPRAD | |
Reference showing the relevant tissue of AQP2 | ||
Description by TissGene annotations | Cancer gene Fused withTSGene |
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO term | PubMed ID | GO:0006833 | water transport | 8584435 | GO:0015793 | glycerol transport | 8584435 | GO:0071280 | cellular response to copper ion | 8584435 | GO:0071288 | cellular response to mercury ion | 8584435 | GO:0006833 | water transport | 8584435 | GO:0015793 | glycerol transport | 8584435 | GO:0071280 | cellular response to copper ion | 8584435 | GO:0071288 | cellular response to mercury ion | 8584435 |
Top |
TissGeneExp for AQP2 |
Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
PRAD | -1.392602241 | 2.326115067 | -3.718717308 | 1.14E-06 | 7.96E-06 |
KIRC | 0.931398293 | 13.26288024 | -12.33148194 | 6.58E-50 | 5.67E-48 |
KIRP | 0.924752807 | 13.29971843 | -12.37496562 | 2.37E-28 | 5.63E-26 |
KICH | 0.561128682 | 13.35782868 | -12.7967 | 2.23E-24 | 4.47E-22 |
LUSC | -1.79885571 | -0.478328259 | -1.320527451 | 1.13E-08 | 3.55E-08 |
STAD | 1.270137182 | -1.100484693 | 2.370621875 | 0.000203 | 0.00140476 |
BLCA | -2.249022686 | -0.845701634 | -1.403321053 | 4.50E-05 | 0.000590014 |
Top |
TissGene-miRNA for AQP2 |
Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
Top |
TissGeneMut for AQP2 |
TissGeneSNV for AQP2 |
nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
- nsSNVs sorted by frequency. |
AAchange | Cancer type | # samples |
p.N68T | LUAD | 2 |
p.R5C | SKCM | 2 |
p.W246* | SKCM | 2 |
p.W246X | SKCM | 2 |
p.N68T | KIRP | 2 |
p.N68T | THCA | 2 |
p.C75F | BLCA | 1 |
p.Y89* | LUAD | 1 |
p.V194I | UCEC | 1 |
p.P242L | LGG | 1 |
p.R152H | UCEC | 1 |
p.P262L | COAD | 1 |
p.A70V | UCEC | 1 |
p.V81D | ACC | 1 |
p.E232D | LUSC | 1 |
p.A97S | SARC | 1 |
p.G158S | SKCM | 1 |
p.N68T | HNSC | 1 |
p.G64R | BLCA | 1 |
p.V81I | STAD | 1 |
p.L143F | STAD | 1 |
p.A117V | SKCM | 1 |
p.D245N | BLCA | 1 |
p.G114R | OV | 1 |
p.A190T | SKCM | 1 |
p.F166L | CESC | 1 |
p.N68T | BRCA | 1 |
p.G51C | COAD | 1 |
p.R85X | SKCM | 1 |
p.R85* | SKCM | 1 |
p.G171D | ESCA | 1 |
p.A87T | UCEC | 1 |
p.S188F | CESC | 1 |
p.G114R | STAD | 1 |
p.T125M | CESC | 1 |
p.G100R | GBM | 1 |
p.V90M | PRAD | 1 |
p.G60S | SKCM | 1 |
p.F23L | LIHC | 1 |
p.N184I | OV | 1 |
p.E3* | OV | 1 |
Top |
TissGeneCNV for AQP2 |
Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
Top |
TissGeneFusions for AQP2 |
Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
TCGAfusionPortal | PRADA | KIRC | TCGA-B0-5691-01A | AQP2-FOXP1 | NA | Chr12:50352664 | Chr3:71007472 |
Top |
TissGeneNet for AQP2 |
Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
Top |
TissGeneProg for AQP2 |
Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Top |
TissGeneClin for AQP2 |
TissGeneDrug for AQP2 |
Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
TissGeneDisease for AQP2 |
Disease information associated with TissGene (DisGeNet, 2016-06-01) |
Disease ID | Disease name | # pubmeds | Source |
umls:C0162283 | Nephrogenic Diabetes Insipidus | 58 | BeFree,CLINVAR,CTD_human,LHGDN,ORPHANET,RGD |
umls:C1563705 | Nephrogenic Diabetes Insipidus, Type I | 46 | BeFree |
umls:C0677501 | Congenital Nephrogenic Diabetes Insipidus | 14 | BeFree |
umls:C1563706 | Nephrogenic Diabetes Insipidus, Type II | 14 | MGD,UNIPROT |
umls:C0032617 | Polyuria | 8 | BeFree |
umls:C0687720 | Central Diabetes Insipidus | 8 | BeFree |
umls:C0011848 | Diabetes Insipidus | 7 | BeFree,LHGDN |
umls:C0011175 | Dehydration | 6 | BeFree |
umls:C0085602 | Polydipsia | 4 | BeFree |
umls:C0020538 | Hypertensive disease | 3 | LHGDN,RGD |
umls:C0575090 | Equilibration disorder | 3 | BeFree |
umls:C0240035 | Interstitial fibrosis | 2 | BeFree |
umls:C0008495 | Chorioamnionitis | 1 | GAD |
umls:C0011847 | Diabetes | 1 | BeFree |
umls:C0011849 | Diabetes Mellitus | 1 | BeFree |
umls:C0011853 | Diabetes Mellitus, Experimental | 1 | RGD |
umls:C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | 1 | GAD |
umls:C0011880 | Diabetic Ketoacidosis | 1 | LHGDN |
umls:C0011881 | Diabetic Nephropathy | 1 | BeFree |
umls:C0011991 | Diarrhea | 1 | BeFree |
umls:C0014175 | Endometriosis | 1 | BeFree |
umls:C0015944 | Fetal Membranes, Premature Rupture | 1 | GAD |
umls:C0016059 | Fibrosis | 1 | LHGDN |
umls:C0018784 | Sensorineural Hearing Loss (disorder) | 1 | BeFree |
umls:C0018801 | Heart failure | 1 | LHGDN |
umls:C0022658 | Kidney Diseases | 1 | BeFree |
umls:C0022661 | Kidney Failure, Chronic | 1 | BeFree,GAD |
umls:C0022876 | Premature Obstetric Labor | 1 | GAD |
umls:C0023890 | Liver Cirrhosis | 1 | LHGDN |
umls:C0025281 | Meniere Disease | 1 | GAD |
umls:C0025517 | Metabolic Diseases | 1 | BeFree |
umls:C0032914 | Pre-Eclampsia | 1 | GAD |
umls:C0040336 | Tobacco Use Disorder | 1 | GAD |
umls:C0042487 | Venous Thrombosis | 1 | GAD,LHGDN |
umls:C0151526 | Premature Birth | 1 | GAD |
umls:C0476089 | Endometrial Carcinoma | 1 | BeFree |
umls:C0878544 | Cardiomyopathies | 1 | CTD_human |
umls:C2919032 | Infection of amniotic sac and membranes, unspecified, unspecified trimester, not applicable or unspecified | 1 | GAD |
umls:C3714756 | Intellectual Disability | 1 | LHGDN |